Beyond cost, Wegovy offers specific advantages worth considering, including a licence to help reduce cardiovascular risk and no interaction with oral contraceptives
In the SURPASS clinical trials, which evaluated tirzepatide in over 10,000 patients with type 2 diabetes, participants experienced average reductions in total cholesterol of approximately 5-10%, LDL-C reductions of 6-13%, and triglyceride reductions of 15-25%, depending on the dose administered
Health issues, genetics, and other factors can cause stubborn weight gain
4 In October 2024, Dr
Ouyang, Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents, Int
The FDA will continue to review the panels recommendation before making a final determination on whether BPC-157 and six other peptides under consideration can be added to the 503A list